Stada Arzneimittel

ots Ad hoc-Service: STADA Arzneimittel AG STADA raises sales in 2000 by +32% to DM 913.7 million

Ad hoc-announcement edited and sent by DGAP. The sender is solely responsible for the contents of this announcement. ----------------------------------------------------

    Bad Vilbel (ots Ad hoc-Service) -      

    STADA Arzneimittel AG increased group sales in 2000 by +32% to DM 913.7 million (1999: DM 692.9 million). The sales target had been raised to DM 870 million in the course of the financial year and even this figure has been significantly exceeded. Sales growth excluding acquisitions is +24% and is based on the broad growth achieved by numerous sales companies. The healthcare companys strategy of concentrating on growth segments in the healthcare market such as generic drugs, self-medication and special pharmaceuticals has once again paid off. STADAs group sales have more than doubled within just three years. STADA now also anticipates a clear increase in earnings and assumes that EBITDA and net income for the year will see even stronger percentage growth than sales in 2000. The final results for the 2000 financial year will be published on April 24 2001. For further information please contact: STADA Arzneimittel AG / Corporate Communications / D-61118 Bad Vilbel Phone: +49(0) 6101 603-113 / Fax: +49(0) 6101 603-506 / E-mail:

    Or visit our website at

    WKN: 725180; Index: SMAX Listed: Amtlicher Handel in Frankfurt und Düsseldorf; Freiverkehr in Berlin, Hamburg, München und Stuttgart

End ----------------------------------------------------- Internet:

Original-Content von: Stada Arzneimittel, übermittelt durch news aktuell

Weitere Meldungen: Stada Arzneimittel

Das könnte Sie auch interessieren: